Spruce Biosciences, Inc. (SPRB)

NASDAQ: SPRB · Real-Time Price · USD

0.1230

0.00 (0.00%)

At close: Apr 17, 2025, 4:00 PM

0.1145

-0.0085 (-6.91%)

After-hours: Apr 17, 2025, 4:47 PM EDT

Spruce Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Revenue	4.91	10.09	-	-	-	Upgrade
Revenue Growth (YoY)	-51.32%	-	-	-	-	Upgrade
Cost of Revenue	46.42	49.43	35.2	-	-	Upgrade
Gross Profit	-41.51	-39.34	-35.2	-	-	Upgrade
Selling, General & Admin	14.64	12.65	12.09	11.37	5.56	Upgrade
Research & Development	-	-	-	30.7	23.85	Upgrade
Operating Expenses	14.64	12.65	12.09	42.07	29.42	Upgrade
Operating Income	-56.15	-51.99	-47.28	-42.07	-29.42	Upgrade
Interest Expense	-0.31	-0.48	-0.42	-0.35	-0.32	Upgrade
Interest & Investment Income	3.42	4.56	1.52	0.12	0.2	Upgrade
Pretax Income	-53.04	-47.92	-46.18	-42.29	-29.54	Upgrade
Net Income	-53.04	-47.92	-46.18	-42.29	-29.54	Upgrade
Net Income to Common	-53.04	-47.92	-46.18	-42.29	-29.54	Upgrade
Shares Outstanding (Basic)	41	39	24	23	6	Upgrade
Shares Outstanding (Diluted)	41	39	24	23	6	Upgrade
Shares Change (YoY)	7.15%	63.68%	0.71%	289.93%	683.77%	Upgrade
EPS (Basic)	-1.29	-1.24	-1.96	-1.81	-4.93	Upgrade
EPS (Diluted)	-1.29	-1.24	-1.96	-1.81	-4.93	Upgrade
Free Cash Flow	-55.96	-33.28	-41.69	-35.97	-27.59	Upgrade
Free Cash Flow Per Share	-1.36	-0.86	-1.77	-1.54	-4.61	Upgrade
Operating Margin	-1143.37%	-515.34%	-	-	-	Upgrade
Profit Margin	-1079.94%	-474.96%	-	-	-	Upgrade
Free Cash Flow Margin	-1139.56%	-329.88%	-	-	-	Upgrade
EBITDA	-56.11	-51.92	-47.21	-42	-29.38	Upgrade
D&A For EBITDA	0.05	0.07	0.07	0.07	0.04	Upgrade
EBIT	-56.15	-51.99	-47.28	-42.07	-29.42	Upgrade

Updated Apr 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q